Medicine Man Technologies, Inc. (SHWZ)

Medicine Man Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	172.45	159.38	108.42	24	10.62
Revenue Growth (YoY)	8.20%	47.00%	351.73%	126.03%	34.00%
Cost of Revenue	123.88	74.35	59.07	17.23	7.62
Gross Profit	48.57	85.03	49.35	6.77	3
Selling, General & Admin	42.87	64.16	38.94	29.68	16.47
Other Operating Expenses	0.07	0.02	22.33	0.03	11.99
Operating Expenses	42.87	64.16	38.94	29.68	16.47
Operating Income	5.7	20.89	-5.11	-22.9	-13.46
Interest Income	0	30.14	7.01	0.04	0.03
Interest Expense	32.07	30.14	7.01	-0.04	-0.16
Other Expense / Income	-11.56	24.46	-24.03	-2.5	4.29
Pretax Income	-14.81	-3.57	18.92	-20.32	-17.56
Income Tax	19.74	14.9	4.4	-0.9	-0.58
Net Income	-34.55	-18.47	14.52	-19.42	-16.98
Shares Outstanding (Basic)	65	54	43	41	34
Shares Outstanding (Diluted)	65	54	101	41	34
Shares Change	20.32%	-47.09%	145.94%	22.16%	21.50%
EPS (Basic)	-0.54	-0.34	0.17	-0.47	-0.50
EPS (Diluted)	-0.54	-0.34	-0.06	-0.47	-0.50
Free Cash Flow	1.59	-3.42	51.67	-10.57	-7.75
Free Cash Flow Per Share	0.02	-0.06	0.51	-0.26	-0.23
Gross Margin	28.16%	53.35%	45.52%	28.23%	28.27%
Operating Margin	3.30%	13.11%	-4.71%	-95.43%	-126.80%
Profit Margin	-20.03%	-11.59%	13.39%	-80.90%	-159.87%
Free Cash Flow Margin	0.92%	-2.14%	47.65%	-44.03%	-73.03%
Effective Tax Rate	-	-	23.24%	-	-
EBITDA	25.96	31.9	3.47	-25.02	-9.47
EBITDA Margin	15.05%	20.02%	3.20%	-104.26%	-89.16%
Depreciation & Amortization	20.26	11.01	8.58	0.48	0.06
EBIT	5.7	20.89	-5.11	-25.5	-9.53
EBIT Margin	3.30%	13.11%	-4.71%	-106.24%	-89.74%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.